metoclopramide has been researched along with Benign Hypothalamic Neoplasms in 1 studies
Metoclopramide: A dopamine D2 antagonist that is used as an antiemetic.
metoclopramide : A member of the class of benzamides resulting from the formal condensation of 4-amino-5-chloro-2-methoxybenzoic acid with the primary amino group of N,N-diethylethane-1,2-diamine.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barbarino, A | 1 |
| De Marinis, L | 1 |
| Mancini, A | 1 |
| Menini, E | 1 |
| D'Amico, C | 1 |
| Passeri, M | 1 |
| Sambo, P | 1 |
| Anile, C | 1 |
| Maira, G | 1 |
1 other study available for metoclopramide and Benign Hypothalamic Neoplasms
| Article | Year |
|---|---|
Prolactin dynamics in patients with non-secretin tumours of the hypothalamic-pituitary region.
Topics: Adenoma; Adenoma, Chromophobe; Adolescent; Adult; Craniopharyngioma; Female; Follicle Stimulating Ho | 1985 |